41 Stocks Moving In Friday's Mid-Day Session

Gainers

• IVERIC bio, Inc. ISEE shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22.
• Echo Global Logistics, Inc. ECHO surged 53.8% to $48.16 after the company agreed to be acquired by private equity firm The Jordan Company.
• Endo International plc ENDP shares climbed 53% to $3.21 after the company said it has settled three consolidated opioid cases pending in Suffolk County Supreme Court in the State of New York. As a result of the settlement, Endo has been severed from the trial.
• PaySign, Inc. PAYS jumped 24.5% to $3.6615. PaySign shares climbed around 25% on Thursday following circulation of an earlier TipRanks article titled '3 "Strong Buy" Stocks Flirting With a Bottom' mentioning the stock.
• Camber Energy, Inc. CEI shares surged 23.8% to $1.6091 after jumping 31% on Thursday.
• Aterian, Inc. ATER gained 23.8% to $12.63.
• Elite Education Group International Limited EEIQ surged 22.7% to $6.41 after jumping 20% on Thursday.
• Affirm Holdings, Inc. AFRM rose 22% to $112.38 after the company reported better-than-expected Q4 sales and issued strong Q1 sales guidance.
• T2 Biosystems, Inc. TTOO rose 19.4% to $1.0350 after the company announced its T2SARS-CoV-2 panel proved capable of detecting the Mu B.1.621 and Iota B.1.526 variants of the SARS-CoV-2 virus.
• Vince Holding Corp. VNCE rose 18.2% to $7.93 after the company reported better-than-expected Q2 results.
• NGM Biopharmaceuticals, Inc. NGM gained 16.7% to $24.80.
• Sonim Technologies, Inc. SONM shares rose 16.3% to $0.6859 after gaining over 21% on Thursday.
• Arbutus Biopharma Corporation ABUS jumped 15.9% to $4.4850 after gaining over 15% on Thursday.
• UP Fintech Holding Limited TIGR rose 14.8% to $15.37 after reporting Q2 results.
• Cedar Realty Trust, Inc. CDR gained 14.1% to $19.40 after the company reported dual-track review of strategic alternatives. The company also named Jennifer Bitterman Chief Financial Officer.
• Greenlane Holdings, Inc. GNLN jumped 13.5% to $2.8950.
• SOS Limited SOS gained 12.4% to $2.9001 after the company reported that revenue in the first half of 2021 totaled $184.5 million, representing an increase of 17 times year over year.
• The Dixie Group, Inc. DXYN jumped 12% to $4.9850.
• IronNet, Inc. IRNT gained 11.5% to $19.30.
• Farmmi, Inc. FAMI climbed 11.3% to $0.4760. Farmmi’s subsidiary Zhejiang Forest Food Co Ltd recently won a new product order for its dried whole Shiitake mushrooms.
• CareMax, Inc. CMAX gained 10.7% to $9.39. Cowen & Co. initiated coverage on CareMax with an Outperform rating and announced a price target of $14.
• National Beverage Corp. FIZZ climbed 9.2% to $51.12 after the company reported Q1 EPS and sales results were higher year over year.
• Katapult Holdings, Inc. KPLT rose 7.8% to $6.79. KeyBanc recently said Katapult is 'well-positioned' to benefit from potential new partnerships and cited 'potential AMZN opportunities.'
• Dave & Buster's Entertainment, Inc. PLAY rose 7.2% to $38.00 after the company reported better-than-expected Q2 results.

Check out these big penny stock gainers and losers

Losers

• Apellis Pharmaceuticals, Inc. APLS shares fell 48.7% to $28.56 after the company reported mixed top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan in 1,258 adults with geographic atrophy secondary to age-related macular degeneration. The OAKS study met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% and 16%, respectively, compared to pooled sham at 12 months. However the DERBY study did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% and 11%, with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.
• Kaival Brands Innovations Group, Inc. KAVL tumbled 45.4% to $5.58 after climbing over 20% on Thursday.
• Mersana Therapeutics, Inc. MRSN fell 35.2% to $9.12.
• Impel NeuroPharma, Inc. IMPL shares dropped 20.2% to $16.85 after the company reported pricing of $45.0 million public offering.
• Lakeland Industries, Inc. LAKE dipped 15.5% to $20.20 after reporting downbeat Q2 sales.
• TMC the metals company Inc. TMC dropped 15.1% to $9.25.
• Tuesday Morning Corporation TUEM dropped 14.5% to $1.9999. Tuesday Morning shares fell 45% on Thursday after the company reported downbeat Q4 earnings.
• Clarus Therapeutics Holdings Inc. CRXT dipped 12.8% to $8.39.
• Hippo Holdings Inc. HIPO fell 12.5% to $6.00. The company earlier reported a Gross Loss Ratio of 161% for the three months ended June 30.
• RLX Technology Inc. RLX fell 12.1% to $6.06.
• RxSight, Inc. RXST dropped 11.3% to $14.19.
• Sumo Logic, Inc. SUMO shares fell 11.3% to $17.85 after the company reported Q2 earnings results and issued Q3 guidance. Piper Sandler downgraded Sumo Logic from Overweight to Neutral and lowered the price target from $24 to $20.
• PharmaCyte Biotech, Inc. PMCB dropped 10.6% to $3.5292.
• Maravai LifeSciences Holdings, Inc. MRVI shares fell 10.1% to $47.95 after the company announced a 20 million share offering of Class A common stock by selling shareholders to be priced at $50 per share..
• Teradata Corporation TDC dipped 9.5% to $50.99. Several analysts raised their price targets on the stock.
• Traeger, Inc. COOK fell 9.1% to $23.24 after the company reported Q2 earnings results.
• The Kroger Co. KR dropped 8.6% to $42.14 despite reporting upbeat quarterly results.